Jerome Boyd-Kirkup

Jerome Boyd-Kirkup is Chief Scientific Officer and co-founder of Hummingbird Bioscience, a precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases. With a passion for integrating scientific disciplines, Jerome co-founded Hummingbird Bioscience to translate systems biology into transformative solutions in precision medicine. Jerome is responsible for overseeing the development of new technologies and intellectual property, designing experimental strategies for drug discovery, leading the development and testing of novel therapeutics, and overseeing the drug pipeline.

Jerome is a molecular systems biologist by background with extensive experience at the interface of computational and wet lab biology, and a career research focus of applying systems biology approaches to tackle human disease.

He holds a Bachelor’s and Master’s degree in Biochemistry from Imperial College London and a PhD in Molecular Biology from Cambridge University.